Literature DB >> 10719651

Biological basis for statin therapy in stroke prevention.

R S Rosenson1.   

Abstract

Hypercholesterolemia has not been considered an important risk factor for stroke; however, statin therapy reduces stroke in coronary heart disease patients. Statins may provide cerebrovascular protection through various mechanisms that include a reduction in the incidence of embolic stroke from cardiac, aortic and carotid sites, stabilization of vulnerable carotid atherosclerotic plaque, and improvement in cerebral blood flow.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10719651     DOI: 10.1097/00019052-200002000-00011

Source DB:  PubMed          Journal:  Curr Opin Neurol        ISSN: 1350-7540            Impact factor:   5.710


  3 in total

1.  Immunohistochemical study on distribution of NF-kappaB and p53 in gerbil hippocampus after transient cerebral ischemia: effect of pitavastatin.

Authors:  Hiroko Tounai; Natsumi Hayakawa; Hiroyuki Kato; Tsutomu Araki
Journal:  Metab Brain Dis       Date:  2007-01-17       Impact factor: 3.584

2.  SPARCL: the glimmer of statins for stroke risk reduction.

Authors:  Annemarie Armani; Peter P Toth
Journal:  Curr Atheroscler Rep       Date:  2007-11       Impact factor: 5.113

Review 3.  Basic mechanisms of stroke prevention with lipid-lowering therapy.

Authors:  R S Rosenson
Journal:  Curr Atheroscler Rep       Date:  2000-03       Impact factor: 5.967

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.